NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019. In Scotland, work is underway to establish similar systems.<\/p>
<\/p>
There are 95,532 specialist doctors registered on the General Medical Council\u2019s Specialist Register. The law allows any specialist doctor to prescribe cannabis-based products for medicinal use. Specialist doctors may decide to prescribe these products on a case-by-case basis, and where it is clinically appropriate. The Department does not hold information on how many of those practitioners operate private practices and are National Health Service or NHS Scotland employees or where they work.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2019-03-12", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "229805"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-03-12T16:17:58.713Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-03-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many patients have been prescribed cannabis-based products for medicinal use; and how many were (a) private prescriptions and (b) prescriptions funded by NHS or NHS Scottish.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4470", "label" : {"_value" : "Biography information for Alan Brown"} } , "tablingMemberConstituency" : {"_value" : "Kilmarnock and Loudoun"} , "tablingMemberPrinted" : [{"_value" : "Alan Brown"} ], "uin" : "229804"} , {"_about" : "http://data.parliament.uk/resources/1083687", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1083687/answer", "answerText" : {"_value" : "
NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019. In Scotland, work is underway to establish similar systems.<\/p>
<\/p>
There are 95,532 specialist doctors registered on the General Medical Council\u2019s Specialist Register. The law allows any specialist doctor to prescribe cannabis-based products for medicinal use. Specialist doctors may decide to prescribe these products on a case-by-case basis, and where it is clinically appropriate. The Department does not hold information on how many of those practitioners operate private practices and are National Health Service or NHS Scotland employees or where they work.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2019-03-12", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "229804"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-03-12T16:17:58.773Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-03-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many medical practitioners are registered to prescribe cannabis-based products for medicinal use; how many of those practitioners (a) operate private practices and (b) are NHS or NHS Scotland employees; and if he will list the (i) Trusts and (ii) Health boards at which each of those NHS and NHS Scotland employee works.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4470", "label" : {"_value" : "Biography information for Alan Brown"} } , "tablingMemberConstituency" : {"_value" : "Kilmarnock and Loudoun"} , "tablingMemberPrinted" : [{"_value" : "Alan Brown"} ], "uin" : "229805"} , {"_about" : "http://data.parliament.uk/resources/1083696", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1083696/answer", "answerText" : {"_value" : "
The Phase II PET-CT Scanning Services procurement commenced on 10 July 2017 and 10 of the 11 contracts are expected to be awarded in the next four weeks. The exception to this is Lot 4, covering the Thames Valley - Buckinghamshire, Oxfordshire and Berkshire West area, where discussions between the parties involved are still underway.<\/p>
<\/p>
NHS England has undertaken two phases of procurement for PET-CT services in England, the first completed during 2014-15 and the second is nearing completion. In both cases, NHS England either has or is on-track to secure significantly improved value, both in the form of additional capital investment into new scanners and new scanning locations, and in terms of reduced price to NHS England. As the Phase II process is still underway, it is not possible to make a final assessment of the cost of procurement. However, these will represent a small proportion of the overall forecast benefits.<\/p>
<\/p>
NHS England undertook a public engagement process between January and February 2016 which was designed to test the phase II procurement approach. The results of this process were incorporated into the final procurement design over the course of 2016/17. A thematic report of the response to public engagement was published in 2017, shortly before the phase II procurement commenced. The report can be found at the following link:<\/p>
<\/p>
https://www.england.nhs.uk/wp-content/uploads/2017/04/pet-ct-engagement-report-april-2017.pdf<\/a><\/p> <\/p> NHS England intends to undertake any further required public involvement duties in respect of planned changes in the location of services following completion of the procurement and in accordance with its responsibilities as described in section 13Q of the NHS Act 2006.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-03-12", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "229812"}
, {"_value" : "229815"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-03-12T16:20:00.933Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-03-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Tomography: Procurement"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 March 2019 to Question 227413 on Tomography: Inhealthcare, what the timescale was for the procurement process for PET-CT scanning services in 2017-18.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4656", "label" : {"_value" : "Biography information for Layla Moran"}
}
, "tablingMemberConstituency" : {"_value" : "Oxford West and Abingdon"}
, "tablingMemberPrinted" : [{"_value" : "Layla Moran"}
], "uin" : "229811"}
, {"_about" : "http://data.parliament.uk/resources/1083709", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1083709/answer", "answerText" : {"_value" : " The Phase II PET-CT Scanning Services procurement commenced on 10 July 2017 and 10 of the 11 contracts are expected to be awarded in the next four weeks. The exception to this is Lot 4, covering the Thames Valley - Buckinghamshire, Oxfordshire and Berkshire West area, where discussions between the parties involved are still underway.<\/p> <\/p> NHS England has undertaken two phases of procurement for PET-CT services in England, the first completed during 2014-15 and the second is nearing completion. In both cases, NHS England either has or is on-track to secure significantly improved value, both in the form of additional capital investment into new scanners and new scanning locations, and in terms of reduced price to NHS England. As the Phase II process is still underway, it is not possible to make a final assessment of the cost of procurement. However, these will represent a small proportion of the overall forecast benefits.<\/p> <\/p> NHS England undertook a public engagement process between January and February 2016 which was designed to test the phase II procurement approach. The results of this process were incorporated into the final procurement design over the course of 2016/17. A thematic report of the response to public engagement was published in 2017, shortly before the phase II procurement commenced. The report can be found at the following link:<\/p> <\/p>